Lv5
1350 积分 2022-10-25 加入
Lipoprotein(a) Reduction in Persons with Cardiovascular Disease
1天前
待确认
Phase 1 Clinical Trial of PPMX‐T003, a Novel Human Monoclonal Antibody Specific for Transferrin Receptor 1, to Evaluate Its Safety, Pharmacokinetics, and Pharmacodynamics
15天前
已完结
The TREM2 agonistic antibody AL002 in early Alzheimer’s disease: a phase 2 randomized trial
23天前
已完结
A Comparison of Spontaneous Tumor Incidence in Charles River Sprague Dawley Rats and Wistar Hannover Rats
1个月前
已完结
Efficacy and safety of adamgammadex for reversing rocuronium-induced deep neuromuscular block: a multicentre, randomised, double-blind, positive-controlled phase III trial
2个月前
已完结
Introduction to the 3RsC's Cross-Platform Microphysiological Systems Evaluation for Drug-Induced Liver Injury in Collaboration with FDA-CDER
2个月前
已完结
Phase 2b Trial of a Na V 1.8 Inhibitor for Acute Pain
2个月前
已完结
Phase 2b Trial of a Na V 1.8 Inhibitor for Acute Pain
2个月前
已完结
Neuronal CCL2 responds to hyperglycaemia and contributes to anxiety disorders in the context of diabetes
2个月前
已完结
Efficacy and safety of intravenous prasinezumab in individuals with early-stage Parkinson's disease on stable symptomatic monotherapy (PADOVA): a phase 2b, multicentre, randomised, double-blind, placebo-controlled study
2个月前
已完结
皖公网安备34019202002308
